These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 14648719)

  • 21. Absence of CHEK2*1100delC mutation in families with hereditary breast cancer in North America.
    Iniesta MD; Gorin MA; Chien LC; Thomas SM; Milliron KJ; Douglas JA; Merajver SD
    Cancer Genet Cytogenet; 2010 Oct; 202(2):136-40. PubMed ID: 20875877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. German populations with infrequent CHEK2*1100delC and minor associations with early-onset and familial breast cancer.
    Rashid MU; Jakubowska A; Justenhoven C; Harth V; Pesch B; Baisch C; Pierl CB; Brüning T; Ko Y; Benner A; Wichmann HE; Brauch H; Hamann U;
    Eur J Cancer; 2005 Dec; 41(18):2896-903. PubMed ID: 16239104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Limited relevance of the CHEK2 gene in hereditary breast cancer.
    Dufault MR; Betz B; Wappenschmidt B; Hofmann W; Bandick K; Golla A; Pietschmann A; Nestle-Krämling C; Rhiem K; Hüttner C; von Lindern C; Dall P; Kiechle M; Untch M; Jonat W; Meindl A; Scherneck S; Niederacher D; Schmutzler RK; Arnold N
    Int J Cancer; 2004 Jun; 110(3):320-5. PubMed ID: 15095295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of CHEK2*1100delC in New York breast cancer cases and controls.
    Offit K; Pierce H; Kirchhoff T; Kolachana P; Rapaport B; Gregersen P; Johnson S; Yossepowitch O; Huang H; Satagopan J; Robson M; Scheuer L; Nafa K; Ellis N
    BMC Med Genet; 2003 Jan; 4():1. PubMed ID: 12529183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer susceptibility genes.
    Lubinski J; Korzen M; Gorski B; Cybulski C; Debniak T; Jakubowska A; Medrek K; Matyjasik J; Huzarski T; Byrski T; Gronwald J; Masojc B; Lener M; Szymanska A; Szymanska-Pasternak J; Fernandez PS; Wokolorczyk D; Piegat A; Ucinski M; Domagala P; Kladny J; Gorecka B; Scott R; Narod S
    J BUON; 2007 Sep; 12 Suppl 1():S23-9. PubMed ID: 17935274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CHEK2*1100delC does not contribute to risk to breast cancer among Malay, Chinese and Indians in Malaysia.
    Thirthagiri E; Cheong LS; Yip CH; Teo SH
    Fam Cancer; 2009; 8(4):355-8. PubMed ID: 19399639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies.
    CHEK2 Breast Cancer Case-Control Consortium
    Am J Hum Genet; 2004 Jun; 74(6):1175-82. PubMed ID: 15122511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic variants associated with breast-cancer risk.
    Narod SA
    Lancet Oncol; 2011 May; 12(5):415-6. PubMed ID: 21514220
    [No Abstract]   [Full Text] [Related]  

  • 29. Detection of the CHEK2 1100delC mutation by MLPA BRCA1/2 analysis: a worthwhile strategy for its clinical applicability in 1100delC low-frequency populations?
    Gutiérrez-Enríquez S; Balmaña J; Baiget M; Díez O
    Breast Cancer Res Treat; 2008 Feb; 107(3):455-7. PubMed ID: 17458694
    [No Abstract]   [Full Text] [Related]  

  • 30. The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population.
    Osorio A; Rodríguez-López R; Díez O; de la Hoya M; Ignacio Martínez J; Vega A; Esteban-Cardeñosa E; Alonso C; Caldés T; Benítez J
    Int J Cancer; 2004 Jan; 108(1):54-6. PubMed ID: 14618615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased risk of breast cancer associated with CHEK2*1100delC.
    Weischer M; Bojesen SE; Tybjaerg-Hansen A; Axelsson CK; Nordestgaard BG
    J Clin Oncol; 2007 Jan; 25(1):57-63. PubMed ID: 16880452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of BRCA1 and BRCA2 mutations in male breast cancer patients in Canada.
    Wolpert N; Warner E; Seminsky MF; Futreal A; Narod SA
    Clin Breast Cancer; 2000 Apr; 1(1):57-63; discussion 64-5. PubMed ID: 11899391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low frequency of CHEK2 1100delC allele in Australian multiple-case breast cancer families: functional analysis in heterozygous individuals.
    Jekimovs CR; Chen X; Arnold J; Gatei M; Richard DJ; Spurdle AB; Khanna KK; Chenevix-Trench G;
    Br J Cancer; 2005 Feb; 92(4):784-90. PubMed ID: 15700044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency of the ATM IVS10-6T-->G variant in Australian multiple-case breast cancer families.
    Lindeman GJ; Hiew M; Visvader JE; Leary J; Field M; Gaff CL; Gardner RJ; Trainor K; Cheetham G; Suthers G; Kirk J
    Breast Cancer Res; 2004; 6(4):R401-7. PubMed ID: 15217508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevalence of mutations BRCA1 5382insC, and CHEK2 1100delC in the population of Siberian region].
    Chasovnikova OB; Mitrofanov DV; Anisimenko MS; Voevoda MI; Kovalenko SP; Liakhovich VV
    Genetika; 2012 Jun; 48(6):768-72. PubMed ID: 22946335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absence of CHEK2 mutations in Spanish families with hereditary breast cancer.
    Bellosillo B; Tusquets I; Longarón R; Pérez-Lezaun A; Bellet M; Fabregat X; Serrano S; Solé F
    Cancer Genet Cytogenet; 2005 Aug; 161(1):93-5. PubMed ID: 16080966
    [No Abstract]   [Full Text] [Related]  

  • 37. Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes.
    Nagel JH; Peeters JK; Smid M; Sieuwerts AM; Wasielewski M; de Weerd V; Trapman-Jansen AM; van den Ouweland A; Brüggenwirth H; van I Jcken WF; Klijn JG; van der Spek PJ; Foekens JA; Martens JW; Schutte M; Meijers-Heijboer H
    Breast Cancer Res Treat; 2012 Apr; 132(2):439-48. PubMed ID: 21614566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Male breast cancer: history, epidemiology, genetic and histopathology].
    Leinung S; Horn LC; Backe J
    Zentralbl Chir; 2007 Oct; 132(5):379-85. PubMed ID: 17907078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant Abnormalities in Male BRCA Mutation Carriers: Results From a Prospectively Screened Cohort.
    Mano R; Tamir S; Kedar I; Benjaminov O; Baniel J; Tabachnik T; Margel D
    JAMA Oncol; 2018 Jun; 4(6):872-874. PubMed ID: 29710070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum.
    Isinger A; Bhat M; Borg A; Nilbert M
    BMC Cancer; 2006 Mar; 6():64. PubMed ID: 16539695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.